Arbor Research
 

Arbor Research Collaborative for Health News 

 
June 2015
In This Issue
Annual Report 2015
Phosphate Binder Pill Burden
EURODOPPS Proposal Winners
Recent Publications

 

Annual Report 2015

 

Our 2015 annual report contains in-depth descriptions of our programs and research findings. The report is available on our website.

We're Hiring! 

curly-table-woman.jpg

Arbor Research offers challenging and rewarding opportunities for highly skilled, intellectual, and dedicated individuals who share our commitment to improving patients' lives. 

 

To view the full list of openings, please visit our Careers page.

 

 

 

 

Join Our Mailing List

 

Like us on Facebook    View our profile on LinkedIn    Follow us on Twitter

 

Tel: +1 (734) 665-4108

            

 

Online Resources
 
 
We are pleased to share news about our projects and publications with you. This newsletter includes summaries of our most recent work to inform medical practice and improve patient care.

 

Simplified Phosphate Binder Pill Regimen

Could Improve Health

 

Hemodialysis patients often have many health problems in addition to their kidney disease. They are often prescribed many oral medications, including phosphate binders, contributing to a high "pill burden."

 

New research from the Dialysis Outcomes and Practice Patterns Study (DOPPS) examines data on pill burden, whether patients reported that they were taking their prescribed phosphate binder pills, and measurements of serum phosphorus and parathyroid hormone levels in patients. Please click here to learn more.   

EURODOPPS Announces Proposal Winners
 
EURODOPPS is a joint venture that brings together the strengths of two initiatives - the Dialysis Outcomes and Practice Patterns Study (DOPPS) and the ERA-EDTA Registry - in collecting and analyzing epidemiological data on hemodialysis patients in Europe.

EURODOPPS asked for proposals from external investigators for possible data analyses; at the 52nd ERA-EDTA Congress in London, they announced seven winning proposals.
  •  Christiane Brechsler (Wurzburg) Beta blockers, cardiovascular events and all-cause mortality in diabetic dialysis patients 
  •  Sophie Liebeuf (Amiens) Impact of therapeutic practices on patient cardiovascular outcomes in dialysis patients
  • Sabine van der Veer (Manchester) Using patient-level characteristics to predict fistula maturation: development and validation of a prognostic model
  • Flore Duranton (Montpellier) Geographical factors and seasonal patterns of blood pressure in dialysis patients
  • James Fotheringham (Sheffield) Modification of the "Long Gap" phenomenon by treatment time and compliance
  • Ionut Nistor (Iasi) Effects of glucose-lowering treatments in patients with type 2 diabetes on dialysis 
  • Albert Power (Bristol) Impact of stroke on quality of life measures in hemodialysis  

For more information please click here.

 

Phosphate binder pill burden, patient-reported non-adherence, and mineral bone disorder markers: Findings from the DOPPS. Fissell RB, et al; Hemodialysis International. Click to view abstract.
 

Evaluating maternal recovery from labor and delivery: bone and levator ani injuries. Miller JM, et al; Amer J Obstet Gynec. Click to view abstract.